The shock news of the week, apparently, is the fact that NICE has spent LOADS of money on themselves instead of spending it on cancer drugs (the b*stards).
Except, erm, as I've posted before, NICE doesn't pay for these drugs - it merely recommends medical treatments based on a cost-benefit analysis (boring I know, and clearly not as efficient as the Daily Mail approach, which is based on ignorant conjecture).
True to form, the Mail have also wheeled-out (not for the first time) a balanced critic of NICE to further their argument.
No comments:
Post a Comment